Sun Pharma Advanced Research Company surges on reporting robust Q3 numbers

03 Feb 2014 Evaluate

Sun Pharma Advanced Research Company is currently trading at Rs. 165.95, up by 4.05 points or 2.50% from its previous closing of Rs. 161.90 on the BSE.

The scrip opened at Rs. 170.00 and has touched a high and low of Rs. 174.70 and Rs. 163.45 respectively. So far 211753 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 179.50 on 09-Dec-2013 and a 52 week low of Rs. 103.15 on 27-Feb-2013.

Last one week high and low of the scrip stood at Rs. 174.70 and Rs. 152.60 respectively. The current market cap of the company is Rs. 3926.93 crore.

The promoters holding in the company stood at 67.13% while Institutions and Non-Institutions held 5.84% and 27.04% respectively.

Sun Pharma Advanced Research Company has reported results for third quarter ended December 31, 2013.

The company has reported net profit of Rs 30.97 crore for the quarter as compared to a net loss of Rs 24.09 crore for the same quarter in the previous year. Total income from operations of the company has increased around 15 fold at Rs 62.95 crore for quarter under review as compared to Rs 4.22 crore for the quarter ended December 31, 2012.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×